Lithium

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Lithium inhibits microglial activation via the toll-like receptor 4 (TLR4).[1]

References[edit | edit source]

  1. Dong, Hongquan; Zhang, Xiang; Dai, Xiaonan; Lu, Shunmei; Gui, Bo; Jin, Wenjie; Zhang, Susu; Zhang, Shu; Qian, Yanning (August 14, 2014), "Lithium ameliorates lipopolysaccharide-induced microglial activation via inhibition of toll-like receptor 4 expression by activating the PI3K/Akt/FoxO1 pathway", Journal of Neuroinflammation, 11: 140, doi:10.1186/s12974-014-0140-4, ISSN 1742-2094, PMC 4149204, PMID 25115727